Eli Lilly and Company
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2009 | 45.4% | 26.8% | 15.8% |
| FY2010 | 40.8% | 26.4% | 16.4% |
| FY2011 | 32.1% | 22.9% | 12.9% |
| FY2012 | 27.7% | 20.2% | 11.9% |
| FY2013 | 26.6% | 21.5% | 13.3% |
| FY2014 | 15.5% | 11.5% | 6.6% |
| FY2015 | 16.5% | 10.7% | 6.8% |
| FY2016 | 19.5% | 12.2% | 7.1% |
| FY2017 | -1.8% | -0.9% | -0.5% |
| FY2018 | 32.9% | 17.0% | 7.4% |
| FY2019 | 319.1% | 50.6% | 21.2% |
| FY2020 | 109.8% | 27.9% | 13.3% |
| FY2021 | 62.2% | 22.9% | 11.4% |
| FY2022 | 58.6% | 24.6% | 12.6% |
| FY2023 | 48.6% | 18.0% | 8.2% |
| FY2024 | 74.2% | 24.7% | 13.5% |
| FY2025 | 77.8% | 30.6% | 18.4% |